antimouse major histocompatibility complex class i (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
90
Structured Review
ATCC
antimouse major histocompatibility complex class i
Antimouse Major Histocompatibility Complex Class I, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antimouse+major+histocompatibility+complex+class+i/10-3%2E6%2E2/pm16499567-21-31-40
Average 90 stars, based on 28 article reviews
Antimouse Major Histocompatibility Complex Class I, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antimouse+major+histocompatibility+complex+class+i/10-3%2E6%2E2/pm16499567-21-31-40
Average 90 stars, based on 28 article reviews
antimouse major histocompatibility complex class i - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Cell Culture:Article Title: Autocrine type I interferon amplifies dendritic cell responses to lipopolysaccharide via the nuclear factor-kappaB/p38 pathways. Article Snippet: .. In some experiments, DC were cultured with a TLR4 ligand, LPS (100 ng/ml, Sigma, Poole, Dorset, UK), and/or recombinant human IFN-a2a (Roche, Basel, Switzerland) for 16 h in the presence of Recombinant:Article Title: Autocrine type I interferon amplifies dendritic cell responses to lipopolysaccharide via the nuclear factor-kappaB/p38 pathways. Article Snippet: .. In some experiments, DC were cultured with a TLR4 ligand, LPS (100 ng/ml, Sigma, Poole, Dorset, UK), and/or recombinant human IFN-a2a (Roche, Basel, Switzerland) for 16 h in the presence of Immunopeptidomics:Article Title: Autocrine type I interferon amplifies dendritic cell responses to lipopolysaccharide via the nuclear factor-kappaB/p38 pathways. Article Snippet: .. In some experiments, DC were cultured with a TLR4 ligand, LPS (100 ng/ml, Sigma, Poole, Dorset, UK), and/or recombinant human IFN-a2a (Roche, Basel, Switzerland) for 16 h in the presence of |